Oscillations in inositol 1,4,5-trisphosphate and diacyglycerol induced by vitamin D3 metabolites in confluent mouse osteoblasts
- 1 September 1993
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 8 (9), 1059-1069
- https://doi.org/10.1002/jbmr.5650080906
Abstract
For the last 5 years, attention has focused on the nongenomic effects of 1,25‐(OH)2D3, but considerably less is known about the mechanisms of the nonnuclear actions of 24,25‐(OH)2D3. The present study examines and compares the rapid (5–90 s) effects of 100 pM to 10 nM 24,25‐(OH)2D3, 10 pM to 1 nM 1,25‐(OH)2D3, and 1–100 nM 25‐OHD3 on the formation of inositol phosphates and lipids in confluent mouse osteoblasts. 24,25‐(OH)2D3 and 25‐OHD3 effects were dose dependent; those of 1,25‐(OH)2D3, were dose dependent in a bell‐shaped manner. The two dihydroxylated metabolites induced a multiphasic response in inositol 1,4,5‐trisphosphate (IP3) formation with three stimulation peaks; the IP3 response to 25‐OHD3 was monophasic. The amplitude of the IP3 response to 24,25‐(OH)2D3 was greater and its oscillation period was slower than that induced by 1,25‐(OH)2D3. The diacylglycerol (DAG) responses to secosteroids showed two stimulation peaks that appeared at different times depending on the secosteroid used. Pretreatment with neomycin totally inhibited the first DAG response; neomycin had no effect on the second peak of DAG induced by 25‐OHD3, whereas it partially blocked the second response of DAG to 24,25‐(OH)2D3 and 1,25‐(OH)2D3. These data show for the first time that 24,25‐(OH)2D3 can modulate phospholipid metabolism in confluent mouse osteoblasts as early as 5–10 s. The first pathway used by all three secosteroids is that of the hydrolysis of phosphatidylinositol 4,5‐bisphosphate via phospholipase C activation, leading to the formation of the two second messengers, IP3 and DAG, since neomycin totally blocked the response. Thus, the action of these secosteroids on the osteoblast membrane may also implicate several steps of the phosphatidylcholine cycle, according to the metabolite tested. Finally, these data point to a direct interaction of vitamin D metabolites with specific membrane recognition moieties.Keywords
Funding Information
- Institut National de la Santé Publique et de la Recherche Médicale (M-88 4016)
This publication has 41 references indexed in Scilit:
- 1,25(OH)2 vitamin D3 stimulates membrane phosphoinositide turnover, activates protein kinase C, and increases cytosolic calcium in rat colonic epithelium.JCI Insight, 1990
- Insulin Rapidly Increases Diacylglycerol by Activating De Novo Phosphatidic Acid SynthesisScience, 1987
- 1,25 Dihydroxyvitamin D increases hepatocyte cytosolic calcium levels. A potential regulator of vitamin D-25-hydroxylase.JCI Insight, 1986
- Neomycin: a specific drug to study the inositol‐phospholipid signalling system?FEBS Letters, 1986
- Genome-independent effects of 1,25-dihydroxy vitamin D-3 on membrane potentialBiochimica et Biophysica Acta (BBA) - Biomembranes, 1983
- VITAMIN D: RECENT ADVANCESAnnual Review of Biochemistry, 1983
- Specific nuclear uptake of 24,25‐dihydroxycholecalciferol, a vitamin D3 metabolite biologically active in cartilageFEBS Letters, 1980
- Inositol phospholipids and cell surface receptor functionBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1975
- Separation of parathyroid hormone and calcitonin-sensitive cells from non-responsive bone cellsNature, 1974
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959